Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bénard

Showing results (21-30 of 86) with videos related to

Pageof 9
Sort By:
Anticancer Research|September 1, 1990
Clinical significance of multiple drug resistance in human cancersJ Bénard, J Bourhis, G Riou
Bulletin Du Cancer|January 1, 1990
[Expression of P-glycoprotein 170 (GP 170) and drug resistance in human cancers]J Bourhis, G Riou, J Bénard
Bulletin Du Cancer|September 30, 1998
[Update on genetic markers of cancer]J Bénard, B Bressac-de Paillerets
Comptes Rendus Hebdomadaires Des Seances De L'Academie Des Sciences. Serie D: Sciences Naturelles|March 3, 1975
[Trypanocidal activity of some ellipticine derivatives against Trypanosoma cruzi cultured in vitro]J Bénard, N Dat-Xuong, G Riou
Nucleic Acids Research|January 1, 1979
Characterization by sedimentation analysis of kinetoplast DNA from Trypanosoma cruzi at different stages of cultureJ Bénard, G Riou, J M Saucier
Bulletin Du Cancer|February 15, 2001
[Id2, a go-between in the Myc-Rb pair]J Bénard, G Raguenez, S Douc-Rasy
Bulletin Du Cancer|September 30, 1998
[Biological markers for the prognosis of neuroblastoma: proposal of a method of analysis]V Combaret, O Delattre, J Bénard, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 1995
Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumorsU M Moll, M LaQuaglia, J Bénard, et al.
International Journal of Cancer|March 15, 1989
Over-expression of MDR1 gene with no DNA amplification in a multiple-drug-resistant human ovarian carcinoma cell lineJ Bénard, J Da Silva, J R Teyssier, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|January 1, 1986
[Chromosome anomalies in 2 cases of human ovarian cancer]M C de Blois, P Boyer, J Bénard, et al.
Pageof 9

Showing results (21-30 of 86) with videos related to

Sort By:
Pageof 9
Anticancer Research|September 1, 1990
Clinical significance of multiple drug resistance in human cancersJ Bénard, J Bourhis, G Riou
Bulletin Du Cancer|January 1, 1990
[Expression of P-glycoprotein 170 (GP 170) and drug resistance in human cancers]J Bourhis, G Riou, J Bénard
Bulletin Du Cancer|September 30, 1998
[Update on genetic markers of cancer]J Bénard, B Bressac-de Paillerets
Comptes Rendus Hebdomadaires Des Seances De L'Academie Des Sciences. Serie D: Sciences Naturelles|March 3, 1975
[Trypanocidal activity of some ellipticine derivatives against Trypanosoma cruzi cultured in vitro]J Bénard, N Dat-Xuong, G Riou
Nucleic Acids Research|January 1, 1979
Characterization by sedimentation analysis of kinetoplast DNA from Trypanosoma cruzi at different stages of cultureJ Bénard, G Riou, J M Saucier
Bulletin Du Cancer|February 15, 2001
[Id2, a go-between in the Myc-Rb pair]J Bénard, G Raguenez, S Douc-Rasy
Bulletin Du Cancer|September 30, 1998
[Biological markers for the prognosis of neuroblastoma: proposal of a method of analysis]V Combaret, O Delattre, J Bénard, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 1995
Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumorsU M Moll, M LaQuaglia, J Bénard, et al.
International Journal of Cancer|March 15, 1989
Over-expression of MDR1 gene with no DNA amplification in a multiple-drug-resistant human ovarian carcinoma cell lineJ Bénard, J Da Silva, J R Teyssier, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|January 1, 1986
[Chromosome anomalies in 2 cases of human ovarian cancer]M C de Blois, P Boyer, J Bénard, et al.
Pageof 9